FDA approves Novartis Rydapt for acute myeloid leukaemia and mastocytosis

The US Food and Drug Administration (FDA) has approved Novartis Rydapt (midostaurin, formerly PKC412) for two indications. Available in 25mg capsules, Rydaptis an oral, multi-targeted inhibitor

US FDA grants fast track status for Oncolytics’ Reolysin to treat metastatic breast cancer

Oncolytics Biotech, a biotechnology company, announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for Reolysin, the company’s proprietary

Natco Pharma launches generic blood cancer drug Pomalidomide in India

NEW DELHI: Natco Pharma today said it has launched a generic version of pomalidomide capsules, used in treatment of a type of blood cancer, in India.“Pomalidomide is a

Supplements and Multivitamins Do we really Need them

Another hard day at work has ended and you are feeling tired. Your energy levels are low and you read an advert about the benefits of taking vitamins or other supplements to tone up and get stronger

Day: May 10, 2017

FDA approves Novartis Rydapt for acute myeloid leukaemia and mastocytosis

US FDA grants fast track status for Oncolytics’ Reolysin to treat metastatic breast cancer

Natco Pharma launches generic blood cancer drug Pomalidomide in India

Supplements and Multivitamins Do we really Need them

Recent Posts

Recent Comments